G · Genpact Limited

The thesis

Genpact's technology segment is growing, but the legacy outsourcing book, 73% of revenue, holds total growth near 7%. The Q3 2026 report, due after the close on 5 November 2026, settles whether technology growth keeps offsetting it. The shares have run up into that date, which raises the bar the report has to clear.

Genpact is moving from outsourced back-office services toward agentic (autonomous, software-driven) operations. The 6 August 2026 results put Advanced Technology Solutions (ATS) revenue at $363 million, up 24.1% year over year. Core Business Services was $980 million, up 1.9%. Management raised its full-year ATS growth outlook to at least 25% and guided Core Business Services flat to slightly down for Q3 (Genpact Q2 results).

The shares closed at $39.20 on 27 October 2026, 17.9% below the 52-week high of $47.73. They closed at $35.33 on 14 October 2026. The three-month gain is 11.6% and the 14-day relative strength index (RSI) is 73.1, above the 70 level that marks stretched momentum. Genpact-specific news in that stretch is thin: an 26 October 2026 headline on scaling agentic operations in manufacturing and Susquehanna's 22 October 2026 move to raise its target to $40 while keeping a Neutral rating.

The narrative is maturing: the pivot is well known, the last operating news was the 8 September 2026 appointment of Sumita Pandit as chief financial officer, and MarketBeat's tally on 1 October 2026 shows two Buy and seven Hold ratings. The 5 November 2026 report is the one event that can reprice the shares. A weekly close below $32 would end the recovery case.

Bullish and bearish views on Genpact Limited

The bull case on Genpact Limited (G), in brief: Technology growth has reported substance. The bear case: Legacy services dominate sales.

Bull case

• Technology growth has reported substance. ATS revenue was $363 million in Q2 2026, 27% of the total, up 24.1% year over year. Management raised the full-year ATS growth outlook to at least 25% on 6 August 2026.
• Contract value is a demand measure that still has to convert into reported revenue.
• Guidance gives a clear test. Genpact guided Q3 revenue to $1.369-$1.382 billion, gross margin up to 36.6% and adjusted earnings per share (EPS) of $1.04-$1.05 in the 6 August 2026 release. A result inside or above those ranges would confirm the mix shift is lifting margin.
• Valuation is low on reported earnings. MarketBeat showed a price-to-earnings ratio of 10.24 on 1 October 2026, and GuruFocus put the forward multiple near 9 times. The shares have since risen, so the multiple is higher than those readings.
• Sell-side targets are drifting up. Susquehanna raised its target to $40 on 22 October 2026. The MarketBeat average target was $39.33 on 1 October 2026, so the close of $39.20 on 27 October 2026 sits at that average.

Bear case

• Legacy services dominate sales. Core Business Services was $980 million, or 73% of Q2 2026 revenue, and management guided it flat to slightly down for Q3. Management also sized a roughly 2 percentage point portfolio-exit headwind on the 6 August 2026 call.
• Cash conversion trails earnings. The Form 10-Q filed 7 August 2026 reported first-half operating cash flow of $48.9 million against net income of $293.7 million. Dividends and buybacks run above that cash flow figure.
• Analysts remain cautious. MarketBeat's consensus on 1 October 2026 is Hold. Baird held Neutral with a $38 target on 7 July 2026, Argus lowered its target to $39 on 9 September 2026, and Susquehanna's $40 target on 22 October 2026 accompanies a Neutral rating. TD Cowen kept Buy but cut its target to $42 on 9 July 2026.

• The rally has priced in some good news. The RSI of 73.1 on 27 October 2026 compares with 29.3 on 18 September 2026, and the earnings date is nine days away. A report that only meets guidance leaves the shares exposed to a return toward the $35 area.

Price setup

The adjusted close was $39.20 on 27 October 2026. The 52-week high is $47.73 and the 18 June 2026 low was $28.77. On 1 October 2026 MarketBeat put the 50-day moving average at $35.14 and the 200-day at $33.75, so the latest close sits well above both of those readings. A wide gap above rising averages into an earnings date is the main crowding evidence; the RSI above 70 points the same way.

The $39 to $40 zone is where the MarketBeat average target ($39.33), Argus ($39) and Susquehanna ($40) cluster. The $32 level in the invalidation condition sits under the 200-day average. A weekly close below it would give back most of the advance from the June low.

Retail attention and options data are not available here, so no conclusion is drawn on them. Insider selling was limited to the August Form 4 sale noted above.

Catalysts, next 30 days

• ~6 November 2026, est.: Form 10-Q for the quarter ended 30 September 2026. Shows nine-month operating cash flow against net income, dividends and buybacks.
• Following days: analyst target changes after the report. Targets clustered at $38 to $42 in the notes above will show whether the sell-side re-rates the pivot.

Elapsed catalysts

• 5 November 2026: Q3 2026 results after the market close, call at 5:00 p.m. ET. Tests ATS growth against the at-least-25% outlook and Core Business Services against the flat-to-slightly-down guide. (passed 1d ago)

What would change the view

The case breaks if technology growth stops covering the services decline. Q3 ATS growth under 20% alongside a year-over-year drop in Core Business Services revenue would confirm that. A cut to the at-least-7% full-year revenue growth outlook issued on 6 August 2026 would do the same.

On price, a weekly close below $32, under the 200-day moving average, would end the recovery case. Nine-month operating cash flow that remains far below net income in the Q3 10-Q would weaken the dividend and buyback support. A clean beat on ATS growth, with Core Business Services at or above the flat guide and cash flow catching up, would strengthen the case.

What it trades with

Genpact trades with Indian-delivery IT services and business process outsourcing names such as Cognizant, EXL and Infosys, which report on the same demand cycle for discretionary enterprise spending. Currency matters because delivery is weighted to India, so the INR/USD rate moves reported margin. The shares also respond to the debate over whether artificial intelligence cuts services pricing for clients, which weighs on legacy outsourcing and helps the technology segment. No sustained correlation figures are cited here.